FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 1875084 · Received October 19, 2010

Report

Report Number
2124215-2010-18739
Event Type
Injury
Date Received
October 19, 2010
Date of Event
September 9, 2010
Report Date
September 9, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE RATE/SENSE PORTION OF THE LEAD WAS CAPPED AND A NEW RATE/SENSE LEAD WAS IMPLANTED. THE SHOCK PORTION OF THE LEAD REMAINS IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED AN INCREASE IN PACING THRESHOLD MEASUREMENTS. LOSS OF CAPTURE WAS ALSO NOTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention 0175| 5076| 4194| N119